An abuse-deterrent stimulant product for consideration deficit-hyperactivity disorder (ADHD) obtained a skeptical review from FDA technical workforce sooner than an advisory committee assembly later this…
An abuse-deterrent stimulant product for consideration deficit-hyperactivity disorder (ADHD) obtained a skeptical review from FDA technical workforce sooner than an advisory committee assembly later this…